NEURO-DEGENERATIVE DISEASE
Clinical trials for NEURO-DEGENERATIVE DISEASE explained in plain language.
Never miss a new study
Get alerted when new NEURO-DEGENERATIVE DISEASE trials appear
Sign up with your email to follow new studies for NEURO-DEGENERATIVE DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New oral drug kamlanoflast enters human testing for ALS
Disease control Not yet recruitingThis study tests an oral drug called Kamlanoflast in 40 adults with ALS. The goal is to see if it is safe, tolerable, and can reduce inflammation or slow disease progression over 24 weeks. Participants must be 18-75 years old, diagnosed with ALS within the last 3 years, and have …
Matched conditions: NEURO-DEGENERATIVE DISEASE
Phase: PHASE1, PHASE2 • Sponsor: Inflammasome Therapeutics • Aim: Disease control
Last updated Jun 16, 2026 12:48 UTC
-
New cycling method could ease MS symptoms
Symptom relief Not yet recruitingThis study tests a new exercise called eccentric cycling for people with multiple sclerosis. Researchers want to see if it improves muscle strength, walking, fatigue, and quality of life better than standard training. The study will include 60 adults with MS who can walk independ…
Matched conditions: NEURO-DEGENERATIVE DISEASE
Phase: NA • Sponsor: University of Liege • Aim: Symptom relief
Last updated Jun 15, 2026 19:03 UTC